ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 625603 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 625603; 2) Community: the network communities that were significantly associated with the response to NSC 625603; 3) Molecule: the relationships between components within communities and NSC 625603; 4) MDR: the compounds that were significantly associated with the NSC 625603.

NSC Compound Enrichment Correlation
NSC 645575 Null 0.0295480456086947 0.454051
NSC 647117 Null 0.0295480456086947 0.18931006
NSC 658103 Null 0.0295480456086947 0.26478655
NSC 659949 14-Bromo-7-O-(2,3,6-trideoxy-2-fluoro-.alpha.-L-talo-hexo- pyranosyl)-4-demethoxydaunomycinone 0.0295480456086947 0.37012667
NSC 683558 Camptothecin Derivative 0.0295480456086947 0.2146253
NSC 683864 Temsirolimus 0.0295480456086947 0.0018011646
NSC 686940 Null 0.0295480456086947 0.35815427
NSC 688021 Phosphorodiamidic acid, N,N-bis(2-bromoethyl)-, (5-nitro-2-thienyl)methyl ester 0.0295480456086947 0.2856016
NSC 699940 Null 0.0295480456086947 0.1570953
NSC 704066 2,3-Dihydro-(3R)-[2-(diethylphosphono)ethylseleno]brefeldin A 0.0295480456086947 -0.16684264
Total:58  Current:43    [First] [Prev] [Next] [Last]